APC and polyposis: Obviously, patients with de novo MMR mutations could be represented in our study, but a number of studies have indicated that Lynch de novo mutation are relatively rare compared to e.g., APC related polyposis and it is estimated that only 1–3% of all HNPCC cases are caused by MMR de novo mutations.57